Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands

Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands

The aim of this study was to describe health-related quality of life (HRQoL) and productivity in Dutch breast cancer patients treated with tamoxifen in an adjuvant setting. Patients who started treatment with a standard dose of tamoxifen and who gave written informed consent, were eligible for parti...

Full description

Bibliographic Details
Main Authors: Anne Kleijburg, C. Louwrens Braal, Justin D. Westenberg, Agnes Jager, Stijn L.W. Koolen, Ron H.J. Mathijssen, Carin A. Uyl-de Groot, Pim Wetzelaer, Hannah Penton
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Early breast cancer
Tamoxifen treatment
Quality of Life
EQ-5D-5 L
FACT-B
Productivity
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222015475

Internet

http://www.sciencedirect.com/science/article/pii/S0753332222015475

Similar Items